Company Filing History:
Years Active: 2011-2016
Title: **Isabelle Solange Lucie Knott: Innovator in Vaccine Development**
Introduction
Isabelle Solange Lucie Knott, a dedicated inventor based in Rixensart, Belgium, has made significant contributions to the field of immunology. With two registered patents to his name, he has focused on developing innovative solutions to combat viral infections and improve cell culture methods.
Latest Patents
One of Knott's latest patents is for an **inactivated dengue virus vaccine with aluminium-free adjuvant**. This groundbreaking work provides immunogenic compositions aimed at preventing and treating diseases caused by the dengue virus. His other notable patent involves **cell culture in culture media free of components of animal origin**. This invention details a process for culturing animal, preferably human, diploid anchorage-dependent cells without using exogenous components of primary animal origin, utilizing a non-animal origin trypsin substitute for passaging cells. This innovation holds promise for producing viruses, viral vaccines, and related applications.
Career Highlights
Currently, Isabelle Knott is associated with **GlaxoSmithKline Biologicals SA**, a global leader in vaccine development. His role at the company allows him to apply his expertise in immunology to create effective vaccine solutions, positively impacting public health.
Collaborations
Knott has collaborated with esteemed colleagues such as **Brigitte Ghislaine Louise Aerts** and **Yves Jules Maurice Ghislain**. These partnerships within the research community foster an environment of innovation and knowledge sharing, further enhancing the quality of their contributions to biomedical research.
Conclusion
Isabelle Solange Lucie Knott's work exemplifies the vital role of inventors in advancing medical science. His patents not only demonstrate innovative thinking but also highlight the importance of developing accessible and effective health solutions. As his career progresses, his ongoing contributions to vaccine research will continue to have a lasting impact on global health.